Evidence map›Paper›PMID 35311159›Full record

ArticleFrontiers in oncology2022

Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study.

Yunze Yang, Olivia M Muller, Satomi Shiraishi, Matthew Harper, Adam C Amundson, William W Wong, Lisa A McGee, Jean-Claude M Rwigema, Steven E Schild, Martin Bues and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Osteoradionecrosis and Proton Therapy-Reply.JAMA otolaryngology-- head & neck surgery · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Yunze YangDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Olivia M MullerDepartment of Dental Specialties, Mayo Clinic Rochester, Rochester, MN, United States.
Satomi ShiraishiDepartment of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States.
Matthew HarperSchool of Dentistry, West Virginia University, Morgantown, WV, United States.
Adam C AmundsonDepartment of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States.
William W WongDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Lisa A McGeeDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Jean-Claude M RwigemaDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Steven E SchildDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Martin BuesDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Mirek FatygaDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Justin D AndersonDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Samir H PatelDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Robert L FooteDepartment of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States.
Wei LiuDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Mayo Clinic Hospital · USWinnMed · USMayo Clinic · USWest Virginia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To retrospectively investigate empirical relative biological effectiveness (RBE) for mandible osteoradionecrosis (ORN) in head and neck (H&N) cancer patients treated with pencil-beam-scanning proton therapy (PBSPT). Methods: We included 1,266 H&N cancer patients, of which, 931 patients were treated with volumetric-modulated arc therapy (VMAT) and 335 were treated with PBSPT. Among them, 26 VMAT and 9 PBSPT patients experienced mandible ORN (ORN group), while all others were included in the control group. To minimize the impact of the possible imbalance in clinical factors between VMAT and PBSPT patients in the dosimetric comparison between these two modalities and the resulting RBE quantification, we formed a 1:1 case-matched patient cohort (335 VMAT patients and 335 PBSPT patients including both the ORN and control groups) using the greedy nearest neighbor matching of propensity scores. Mandible dosimetric metrics were extracted from the case-matched patient cohort and statistically tested to evaluate the association with mandibular ORN to derive dose volume constraints (DVCs) for VMAT and PBSPT, respectively. We sought the equivalent constraint doses for VMAT so that the critical volumes of VMAT were equal to those of PBSPT at different physical doses. Empirical RBEs of PBSPT for ORN were obtained by calculating the ratio between the derived equivalent constraint doses and physical doses of PBSPT. Bootstrapping was further used to get the confidence intervals. Results: Clinical variables of age, gender, tumor stage, prescription dose, chemotherapy, hypertension or diabetes, dental extraction, smoking history, or current smoker were not statistically related to the incidence of ORN in the overall patient cohort. Smoking history was found to be significantly associated with the ORN incidence in PBSPT patients only. V40Gy[RBE], V50Gy[RBE], and V60Gy[RBE] were statistically different ( Conclusions: Our study suggested that RBEs were larger than 1.1 at moderate doses (between 40 and 60 Gy[RBE=1.1]) with high LET for mandible ORN. RBEs are underestimated in current clinical practice in PBSPT. The derived DVCs can be used for PBSPT plan evaluation and optimization to minimize the incidence rate of mandible ORN.

Indexed as

dose LET volume histogram (DLVH)head and neck (H&N) cancerlinear energy transfer (LET)mandibular osteoradionecrosispencil beam scanning proton therapy (PBSPT)relative biological effectivenessvolume modulated arc-therapy (VMAT)

Identifiers

PMID35311159
PMCPMC8928456
OpenAlexW4214863867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.